ClinicalTrials.Veeva

Menu

Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate (SFP-PROSTATE)

U

University Medical Center Groningen (UMCG)

Status

Enrolling

Conditions

Prostate Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT03034187
H1998-12/SFP-Prostate

Details and patient eligibility

About

The goal is to gain insight in the development and course of the toxicity after a curative treatment of prostate cancer

Full description

All with curative intent treated prostate cancer patients will be enrolled in the SFP (Standard Follow-up Programme). It also includes the post -operative adjuvant treatments and the patients with positive lymph nodes.

Patients will complete weekly questionnaires to score the patient -rated toxicity. Biweekly patients are seen by the treating radiation oncologist and / or AIOS in which the physician -rated toxicity is scored. In the follow-up will always patient -rated toxicity and physician -rated toxicity can be determined.

Use of an SFP should yield a profit for the practitioner , such as the automatic generation of letters. This should apply to all SFPs .

Quality of life and toxicity in patients will be completed on the touch-screen computers at FU visits.

Enrollment

10,000 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All curative treated patients with prostatecancer( with positive lymph nodes)
  • All patients who will be treated with RT( including post-operative, adjuvant treatments)
  • Are willing to fill in toxicity and QOL-questionnarys (QLQ-PR25 en de QLQ-C30)

Exclusion criteria

Patients who are not willing to fill in toxicity and QOL-questionnarys Patients who will not get RT Non-curative or palliative treated patients (with bone mestasis) Non-prostate cancer-patients

Trial contacts and locations

1

Loading...

Central trial contact

S. Aluwini, MD PhD; P. Veldhuijzen van Zanten

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems